|
[1]
|
Lidani KCF, Andrade FA, Bavia L, Damasceno FS, Beltrame MH, Messias-Reason IJ, et al. Chagas disease: from discovery to a worldwide health problem. Front Public Health 2019;7:166. http://dx.doi.org/10.3389/fpubh.2019.00166CrossRef
|
|
[2]
|
World Health Organization. Celebrating World Chagas Disease Day for the first time in 2020. https://www.who.int/news-room/events/detail/2020/04/14/default-calendar/celebrating-world-chagas-disease-day-for-the-first-time-in-2020. [2020-03-14].https://www.who.int/news-room/events/detail/2020/04/14/default-calendar/celebrating-world-chagas-disease-day-for-the-first-time-in-2020 |
|
[3]
|
Kropf SP, Sá MR. The discovery of Trypanosoma cruzi and Chagas disease (1908-1909): tropical medicine in Brazil. Hist Ciênc Saúde Manguinhos 2009;16(Suppl 1):13 − 34. http://dx.doi.org/10.1590/s0104-59702009000500002CrossRef
|
|
[4]
|
Liu Q, Zhou XN. Preventing the transmission of American trypanosomiasis and its spread into non-endemic countries. Infect Dis Poverty 2015;4:60. http://dx.doi.org/10.1186/s40249-015-0092-7CrossRef
|
|
[5]
|
Pereira PCM, Navarro EC. Challenges and perspectives of Chagas disease: a review. J Venom Anim Toxins Incl Trop Dis 2013;19(1):34. http://dx.doi.org/10.1186/1678-9199-19-34CrossRef
|
|
[6]
|
Coura JR, Viñas PA. Chagas disease: a new worldwide challenge. Nature 2010;465(7301):S6 − 7. http://dx.doi.org/10.1038/nature09221CrossRef
|
|
[7]
|
Schmunis GA, Yadon ZE. Chagas disease: a Latin American health problem becoming a world health problem. Acta Trop 2010;115(1 − 2):14 − 21. http://dx.doi.org/10.1016/j.actatropica.2009.11.003CrossRef
|
|
[8]
|
Jackson Y, Pinto A, Pett S. Chagas disease in Australia and New Zealand: risks and needs for public health interventions. Trop Med Int Health 2014;19(2):212 − 8. http://dx.doi.org/10.1111/tmi.12235CrossRef
|
|
[9]
|
Antinori S, Galimberti L, Bianco R, Grande R, Galli M, Corbellino M. Chagas disease in Europe: a review for the internist in the globalized world. Eur J Intern Med 2017;43:6 − 15. http://dx.doi.org/10.1016/j.ejim.2017.05.001CrossRef
|
|
[10]
|
Prata A. Clinical and epidemiological aspects of Chagas disease. Lancet Infect Dis 2001;1(2):92 − 100. http://dx.doi.org/10.1016/S1473-3099(01)00065-2CrossRef
|
|
[11]
|
Rassi Jr A, Rassi A, Marin-Neto JA. Chagas disease. Lancet 2010;375(9723):1388 − 402. http://dx.doi.org/10.1016/S0140-6736(10)60061-XCrossRef
|
|
[12]
|
Schofield CJ, Jannin J, Salvatella R. The future of Chagas disease control. Trends Parasitol 2006;22(12):583 − 8. http://dx.doi.org/10.1016/j.pt.2006.09.011CrossRef
|
|
[13]
|
Liu Q, Guo YH, Zhang Y, Zhou ZB, Zhang LL, Zhu D, et al. First records of Triatoma rubrofasciata (De Geer, 1773) (Hemiptera, Reduviidae) in Foshan, Guangdong Province, Southern China. Infect Dis Poverty 2017;6(1):129. http://dx.doi.org/10.1186/s40249-017-0342-yCrossRef
|
|
[14]
|
Shi YL, Wei YB, Feng XY, Liu JF, Jiang ZH, Ou FQ, et al. Distribution, genetic characteristics and public health implications of Triatoma rubrofasciata, the vector of Chagas disease in Guangxi, China. Parasit Vectors 2020;13(1):33. http://dx.doi.org/10.1186/s13071-020-3903-zCrossRef
|